statut_color,statut,statut_name,NCTId,eudraCT,CTIS,completion_year,clinical_trial_title,acronym,intervention_type
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT01916785,,,2013,A PROSPECTIVE RANDOMIZED PHASE II STUDY EVALUATING THE OPTIMIZATION OF THE RESIDUAL PLASMATIC LEVEL OF DASATINIB (SPRYCEL¬Æ) IN PATIENTS NEWLY DIAGNOSED WITH CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML).,OPTIM-DASA,DRUG
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT03166969,,,2013,,HOLTER-21J,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02963545,,,2016,Simultaneous Assessments of Serotonin and Kynurenine Pathways Parameters in Patients Shortly (Less Than 4 Hours and a Half) After the Onset of a Cerebral Infarction,,BIOLOGICAL
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02888964,,,2016,A Study to Assess Efficacy and Safety of Pioglitazone as Add-On Therapy to Imatinib Mesylate in CP-CML Patients in Major Molecular Response,ACTIM,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02888990,,,2016,An Open Label Phase II Study to Evaluate the Efficacy and Safety of Induction and Consolidation Therapy With Dasatinib in Combination With Chemotherapy in Patients Aged 55 Years and Over With Philadelphia Chromosome Positive (Ph+ or BCR-ABL+) Acute Lymphoblastic Leukemia (ALL).,EWALLPH01,DRUG
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT02883959,,,2016,,Painkiller,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02896842,,,2016,A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate (Glivec¬Æ) Plasmatic Through Level in Patients Newly Diagnosed With Chronic Phase Chronic Myelogenous Leukaemia (CP-CML).,OPTIMIMATINIB,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02882568,,,2016,Analysis of Immune Response In Bacterial Infection of Obese Subject,ARIIBO,BIOLOGICAL
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02901015,,,2017,Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients Functioning (EVACO),EVACO,BEHAVIORAL
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT03115242,,,2017,Contrast Enhanced Ultrasound of Carotid Plaque in Acute Ischemic Stroke,CUSCAS,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01946750,,,2017,,SERODIFF,BIOLOGICAL
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02896374,,,2017,Normal and Abnormal Event Related Potentials During Attribution of Intentions to Others and Resolution of Emotional Conflicts in Schizophrenia,SERC,BEHAVIORAL
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT02349074,,,2019,Digestive ENdoscopy afTeR Out-of-hospitAl Cardiac arresT,ENTRACT,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02894177,,,2020,Is Transcutaneous Carbon Dioxide Pressure (tcPCO2) Monitoring During Spontaneous Breathing Trials Useful to Predict Extubation Failure in Mechanically Ventilated Patients in the ICU?,tcPCO2,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT03030482,,,2020,Evaluation of Touch Massage on Anxiety in Critically Ill Patients : a Randomised Controlled Trial Study (REaLAX),REaLAX,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT04363528,,,2021,Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,COVIDOP-DVT,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT03973385,,,2022,Evaluation of Efficacy of Cryotherapy for Skin Anesthesia During Arterial Puncture for Blood Gas in Critically Ill Patients. SNOW Study,SNOW,DEVICE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02473146,,,2023,Etude Exploratoire randomis√©e Comparant le Traitement Par Gemtuzumab Ozogamicin /Cytarabine au Traitement Standard Par Idarubicine/Cytarabinechez Les Sujets √¢g√©s de 60 √† 80 Ans et pr√©sentant Une LAM et un Caryotype Non d√©favorable,ALFA1401,DRUG
